Eli Lilly Raises 2026 Revenue Outlook to $91–92 Billion
Lilly raised 2026 revenue guidance to $91–92 billion after Q3 EPS of $7.48 beat estimates of $6.26, as Mounjaro sales jumped 65% to $10.72 billion.
Topic
Mounjaro
Topic
Topic
Topic
Lilly raised 2026 revenue guidance to $91–92 billion after Q3 EPS of $7.48 beat estimates of $6.26, as Mounjaro sales jumped 65% to $10.72 billion.